Prognosis and clinical management of asymptomatic family members with RYR2 -mediated catecholaminergic polymorphic ventricular tachycardia: a review
Cardiology in the Young · 2024
DOI: 10.1017/s1047951124000714 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiology in the Young, 2024. Verfasst von Puck J Peltenburg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, UMC, University of A…. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Tachycardia, Ventricular, Electrocardiography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite its low prevalence, the potential diagnosis of catecholaminergic polymorphic ventricular tachycardia (CPVT) should be at the forefront of a paediatric cardiologists mind in children with syncope during exercise or emotions. Over the years, the number of children with a genetic diagnosis of CPVT due to a (likely) pathogenic RYR2 variant early in life and prior to the onset of symptoms has increased due to cascade screening programmes. Limited guidance for this group of patients is currently available. Therefore, we aimed to summarise currently available literature for asymptomatic patients with a (likely) pathogenic RYR2 variant, particularly the history of CPVT and its genetic architecture, the currently available diagnostic tests and their limitations, and the development of a CPVT phenotype – both electrocardiographically and symptomatic – of affected family members. Their risk of arrhythmic events is presumably low and a phenotype seems to develop in the first two decades of life. Future research should focus on this group in particular, to better understand the development of a phenotype over time, and therefore, to be able to better guide clinical management – including the frequency of diagnostic tests, the timing of the initiation of drug therapy, and lifestyle recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, UMC, University of Amsterdam, Heart Centre, Amsterdam, The Netherlands.
- Department of Pediatric Cardiology, Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands.
- Department of Pediatric Cardiology, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, The Netherlands.
ORCID-Profile: Puck J Peltenburg
Zitieren
APA
Peltenburg, P. J., Gibson, H., Wilde, A. A. M., van der Werf, C., Clur, S. B., & Blom, N. A. (2024). Prognosis and clinical management of asymptomatic family members with RYR2 -mediated catecholaminergic polymorphic ventricular tachycardia: a review. Cardiology in the Young. https://doi.org/10.1017/s1047951124000714
Vancouver
Peltenburg PJ, Gibson H, Wilde AAM, van der Werf C, Clur SB, Blom NA. Prognosis and clinical management of asymptomatic family members with RYR2 -mediated catecholaminergic polymorphic ventricular tachycardia: a review. Cardiology in the Young. 2024. doi:10.1017/s1047951124000714
BibTeX
@article{Peltenburg2024,
author = {Peltenburg, Puck J and Gibson, Harry and Wilde, Arthur A M and van der Werf, Christian and Clur, Sally-Ann B and Blom, Nico A},
title = {Prognosis and clinical management of asymptomatic family members with RYR2 -mediated catecholaminergic polymorphic ventricular tachycardia: a review},
journal = {Cardiology in the Young},
year = {2024},
doi = {10.1017/s1047951124000714}
}
EUVIMED